{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
First approved in 2006
Source:
Embutramide by PROCOS S.p.A.
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Embutramide is a veterinary, CNS active medicine used for euthanasia in dogs. The drug is marketed under the name Tributame in the USA and under the name Tanax in Europe. Human consumption of the drug is usually associated with suicide attempts.
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2006)
Source URL:
First approved in 2006
Source:
21 CFR 348
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Pyritidium (also known as Prothidium) is a Phenanthridinium derivative with powerful prophylactic activity against cattle trypanosomiasis. Prothidium dibromide was used for the treatment of sleeping sickness in man and nagana in cattle. Pyritidium is thought to have antiviral properties and to interfere with the synthesis of nucleic acids in a variety of organisms.
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2008)
Source URL:
First approved in 2006
Source:
21 CFR 352
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2006)
Source URL:
First approved in 2006
Source:
505G(a)(3)
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
First approved in 2006
Source:
21 CFR 347
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Benzyl cinnamate (also known as Jacobson's solution) was used to treat chronic salpingitis, and in combination with vitamin A to treat cerebrovascular lesions. In addition, it is used in heavy oriental perfumes and as a fixative and as a flavoring agent.
Status:
First approved in 2006
Source:
21 CFR 358H
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Dipyrithione is a pyrithione derivate used as bactericide and fungicide. The drug was marketed under the name Crimanex in the form of shampoo for the treatment of dandruff, however it is no longer available on the manufacturer website (Drossa Pharm).
Status:
Possibly Marketed Outside US
Source:
NCT00515151: Phase 4 Interventional Completed Catheterization, Central Venous
(2002)
Source URL:
First approved in 2006
Source:
21 CFR 333E
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Propyl alcohol or n-Propanol, primary alcohol that is used as a solvent and chemical intermediate in the pharmaceutical, chemical and food industries. It was found that n-Propanol exhibited low acute toxicity for animals via the dermal, inhalation, and oral routes of exposure. n-Propanol has no evidence of carcinogenicity or mutagenicity. This compound is not a reproductive toxicant at levels expected from using it as an inert ingredient in pesticide formulations.
Status:
Possibly Marketed Outside US
Source:
M006
(2017)
Source URL:
First approved in 2005
Source:
M006
Source URL:
Class (Stereo):
CHEMICAL (MIXED)
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2005)
Source URL:
First approved in 2005
Source:
21 CFR 352
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2005)
Source URL:
First approved in 2005
Source:
21 CFR 352
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
ETHYLBISIMINOMETHYLGUAIACOL MANGANESE CHLORIDE (EUK-134) is a synthetic manganese-porphyrin complex. It is a superoxide dismutase and catalase mimetic. EUK-134 can protect ischemically injured rat kidneys from ischemia-reperfusion syndrome when administered just before reperfusion. EUK-134 can markedly protect primary rat cortical neurons from hydrogen peroxide mediated oxidative stress. Treatment with EUK-134 prevented the force decrease and the actin modifications in pulmonary hypertension diaphragm bundles. EUK-134 is identified as a novel approach to attenuate cardiac hypertrophy and lends scope for the development of EUK-134 as a therapeutic agent in the management of human cardiovascular disease.
